Trial NCT04315298
Publication Sivapalasingam S (2), 2021
Primary outcome on the report: Proportion of critical patients receiving MV at baseline with ≥ 1-point improvement in clinical status on a 7-point ordinal scale from baseline to day 22 (phase 3)

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.